Lack of Adaptation to Human Tetherin in HIV-1 Group O and P
Overview
Affiliations
Background: HIV-1 viruses are categorized into four distinct groups: M, N, O and P. Despite the same genomic organization, only the group M viruses are responsible for the world-wide pandemic of AIDS, suggesting better adaptation to human hosts. Previously, it has been reported that the group M Vpu protein is capable of both down-modulating CD4 and counteracting BST-2/tetherin restriction, while the group O Vpu cannot antagonize tetherin. This led us to investigate if group O, and the related group P viruses, possess functional anti-tetherin activities in Vpu or another viral protein, and to further map the residues required for group M Vpu to counteract human tetherin.
Results: We found a lack of activity against human tetherin for both the Vpu and Nef proteins from group O and P viruses. Furthermore, we found no evidence of anti-human tetherin activity in a fully infectious group O proviral clone, ruling out the possibility of an alternative anti-tetherin factor in this virus. Interestingly, an activity against primate tetherins was retained in the Nef proteins from both a group O and a group P virus. By making chimeras between a functional group M and non-functional group O Vpu protein, we were able to map the first 18 amino acids of group M Vpu as playing an essential role in the ability of the protein to antagonize human tetherin. We further demonstrated the importance of residue alanine-18 for the group M Vpu activity. This residue lies on a diagonal face of conserved alanines in the TM domain of the protein, and is necessary for specific Vpu-tetherin interactions.
Conclusions: The absence of human specific anti-tetherin activities in HIV-1 group O and P suggests a failure of these viruses to adapt to human hosts, which may have limited their spread.
Complex Relationships between HIV-1 Integrase and Its Cellular Partners.
Rozina A, Anisenko A, Kikhai T, Silkina M, Gottikh M Int J Mol Sci. 2022; 23(20).
PMID: 36293197 PMC: 9603942. DOI: 10.3390/ijms232012341.
Site-Specific Evolutionary Rate Shifts in HIV-1 and SIV.
Gelbart M, Stern A Viruses. 2020; 12(11).
PMID: 33207801 PMC: 7696578. DOI: 10.3390/v12111312.
Heusinger E, Deppe K, Sette P, Krapp C, Kmiec D, Kluge S J Virol. 2018; 92(18).
PMID: 29976668 PMC: 6146695. DOI: 10.1128/JVI.00276-18.
Foster T, Pickering S, Neil S Front Immunol. 2018; 8:1853.
PMID: 29354117 PMC: 5758531. DOI: 10.3389/fimmu.2017.01853.
Sato K, Misawa N, Takeuchi J, Kobayashi T, Izumi T, Aso H J Virol. 2017; 92(4).
PMID: 29212937 PMC: 5790958. DOI: 10.1128/JVI.01905-17.